6534.TW · CHBIO
Taiwan · RS rating 59 · As of 2026-10-08
| Price | 94.50 TWD |
|---|---|
| 1-day change | +0.5% |
| RS rating (overall / 1M / 3M / 12M) | 59 / 62 / 67 / 34 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 36 / 34 / 28 |
| Industry group (rank) | Biotechnology & Medical Care (50) |
| EPS growth Q/Q | -64.2% |
| Sales growth Q/Q | -47.2% |
| Distance from 52-week high | +17.8% |
| Market cap (USD) | $293.0M |